SCHEMBL4719403

SCHEMBL4719403

O=C1Nc2cccc(F)c2C12CCCCC2

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 1/20 0.50
▸ TNKS2 Q9H2K2 1/20 0.50
▸ PGR P06401 11/20 0.47
▸ PDE7A Q13946 2/20 0.42
▸ BACE1 P56817 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ OPRM1 P35372 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ OPRL1 P41146 1/20 0.37
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24481758 0.98 TNKS (0.51) TNKSTNKS2PGRPDE7ABACE1
SCHEMBL15004855 0.95 TNKS (0.51) TNKSTNKS2PGRPDE7ABACE1
SCHEMBL31472145 0.95 TNKS (0.51) TNKSTNKS2PGRPDE7ABACE1
SCHEMBL3866633 0.91 TNKS (0.50) TNKSTNKS2PGRPDE7ABACE1
SCHEMBL31472193 0.91 TNKS (0.50) TNKSTNKS2PGRPDE7ABACE1
SCHEMBL20954874 0.85 BACE1 (0.51) TNKSTNKS2PGRBACE1OPRM1
SCHEMBL15650376 0.83 TNKS (0.46) TNKSTNKS2PGRBACE1HDAC4
SCHEMBL5481718 0.81 PGR (0.49) TNKSTNKS2PGRPDE7A
SCHEMBL4719333 0.81 PDE7A (0.57) TNKSTNKS2PGRPDE7ABACE1
SCHEMBL30881935 0.77 PGR (0.46) TNKSTNKS2PGRPDE7ABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931631-A1 1- (1H- INDOL- 1-YL) -3- (METHYLAMINO) -1- PHENYLPROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) Wyeth a Corporation of the State of Delaware (US) 2008-06-18 — — EP disclosed
WO-2007041023-A1 1- (1H- INDOL- 1-YL) -3- (METHYLAMINO) -1- PHENYLPROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) WYETH (US) 2007-04-12 — — WO disclosed
Send feedback